EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Suet-Kei Wu iD, Kai-Jie Yang iD, Wen-Chun Liu iD, Ikbal Andrian Malau iD, Halliru Zailani iD, Cheng-Ho Chang, Shih-Yi Huang iD, Jane Pei-Chen Chang iD, Wei-Che Chiu iD, Kuan-Pin Su iD

Nutrients · 2024

DOI: 10.3390/nu16213688 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Suet-Kei Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung 404, Taiwan. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Major Depressive Disorder, Antidepressive Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council (NSTC), An-Nan Hospital, China Medical University, Tainan, Taiwan, Higher Education Sprout Project by the Ministry of Education (MOE), Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) have demonstrated protective effects in major depressive disorder (MDD) patients receiving antidepressant treatment. However, there have been a few double-blind randomized controlled trials focused on n-3 PUFAs as monotherapy in MDD, and the outcomes have been mixed. This study aimed to assess the clinical effects of n-3 PUFAs monotherapy in patients with MDD.

Methods

A total of 60 patients with MDD participated in this 12-week double-blind randomized controlled trial. They were randomized to either the n-3 PUFAs group (n = 30; 3.2 g of eicosapentaenoic acid, EPA and docosahexaenoic acid, DHA per day) or the placebo group (n = 30; 3.2 g of soybean oil per day). The severity of depression was evaluated using the Hamilton Rating Scale for Depression (HRSD).

Results

The n-3 PUFAs group had a significantly lower HRSD score compared with the placebo group at week 4 (p = 0.004), week 6 (p = 0.006), week 8 (p = 0.004), and week 12 (p = 0.01). The n-3 PUFAs group showed slightly higher rates for both remission (26.7% vs. 10%, p = 0.095) and response (23.3% vs. 6.7%, p = 0.145) compared with the placebo group at week 12, but these differences did not reach statistical significance.

Conclusions

These findings suggested that monotherapy of n-3 PUFAs could improve depression and potentially serve as an alternative option for MDD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3Major Depressive DisorderAntidepressive AgentsHumansDouble-Blind MethodMaleFemalePilot ProjectsAdultMiddle AgedTreatment OutcomeEicosapentaenoic AcidDocosahexaenoic AcidsDietary Supplements

Stichwörter der Autor:innen

RCTdepressionmonotherapyn-3 PUFAs

Substanzen

Fatty Acids, Omega-3Antidepressive AgentsEicosapentaenoic AcidDocosahexaenoic Acids

Autor:innen und Institutionen

  • Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung 404, Taiwan.
  • Graduate Institute of Nutrition, China Medical University, Taichung 404, Taiwan.
  • Department of Nursing, National Tainan Junior College of Nursing, Tainan 700, Taiwan.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan.
  • Department of Psychiatry, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.
  • School of Nutrition and Health Sciences, Taipei Medical University, Taipei 110, Taiwan.

ORCID-Profile: Suet-Kei Wu, Kai-Jie Yang, Wen-Chun Liu, Ikbal Andrian Malau, Halliru Zailani, Shih-Yi Huang, Jane Pei-Chen Chang, Wei-Che Chiu, Kuan-Pin Su

Förderung

  • National Science and Technology Council (NSTC)
  • An-Nan Hospital, China Medical University, Tainan, Taiwan
  • Higher Education Sprout Project by the Ministry of Education (MOE), Taiwan
  • China Medical University, Taichung, Taiwan
  • China Medical University Hospital, Taichung, Taiwan.
  • Ministry of Education (MOE), Taiwan
  • China Medical University Hospital, Taichung, Taiwan

Zitieren

APA

Wu, S. K., Yang, K. J., Liu, W. C., Malau, I. A., Zailani, H., Chang, C. H., Huang, S. Y., Chang, J. P., Chiu, W. C., & Su, K. P. (2024). The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Nutrients. https://doi.org/10.3390/nu16213688

Vancouver

Wu SK, Yang KJ, Liu WC, Malau IA, Zailani H, Chang CH, et al. The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study. Nutrients. 2024. doi:10.3390/nu16213688

BibTeX
@article{Wu2024,
  author = {Wu, Suet-Kei and Yang, Kai-Jie and Liu, Wen-Chun and Malau, Ikbal Andrian and Zailani, Halliru and Chang, Cheng-Ho and Huang, Shih-Yi and Chang, Jane Pei-Chen and Chiu, Wei-Che and Su, Kuan-Pin},
  title = {The Efficacy of Omega-3 Fatty Acids as the Monotherapy for Depression: A Randomized, Double-Blind, Placebo-Controlled Pilot Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16213688}
}
Kostenlos starten →